Publikationen, an denen er mitarbeitet JOSE JAVIER MEANA MARTINEZ (61)

2024

  1. Clinical Predictors of Mood Disorders and Prevalence of Neuropsychiatric Symptoms in Patients with Systemic Lupus Erythematosus

    Journal of Clinical Medicine, Vol. 13, Núm. 18

  2. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain

    British Journal of Pharmacology

2023

  1. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487

  2. Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 348-365

  3. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

    Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350

  4. Psilozibinaren administrazio akutuaren eraginen ebaluazioa garun kortexean serotonina, noradrenalina eta dopamina mailak neurtuz: garun-mikrodialisiaren bidez burututako ikerlana esna dauden saguetan

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

2022

  1. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

    Addiction Biology, Vol. 27, Núm. 6

  2. High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers

    International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478

  3. Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. Enfermedades mentales y nutrición saludable. Nuevas alternativas para su tratamiento

    Revista española de nutrición comunitaria = Spanish journal of community nutrition, Vol. 27, Núm. 1

  2. In Vivo Brain Microdialysis of Monoamines

    Neuromethods (Humana Press Inc.), pp. 489-512

  3. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways

    Frontiers in Pharmacology, Vol. 12

  4. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  5. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2020

  1. Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for Gαi1- and neutral antagonism for Gαq/11-proteins in human brain cortex

    European Neuropsychopharmacology, Vol. 36, pp. 83-89

  2. Serum β-endorphin levels are associated with addiction to suicidal behavior: A pilot study

    European Neuropsychopharmacology, Vol. 40, pp. 38-51

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

  2. Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons

    Brain Structure and Function, Vol. 224, Núm. 3, pp. 1219-1244

  3. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus

    Neuropharmacology, Vol. 158

  4. Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression

    Molecular Neurobiology, Vol. 56, Núm. 4, pp. 3038-3052